Medical/Pharmaceuticals

RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues

Ophthalmologist-developed and clinically tested, the new peptide-powered formula pairs advanced time-release technology with high-performance lash conditioning VENTURA, Calif., Sept. 29, 2026 /PRNewswire/ -- RevitaLash® Cosmetics, the internationally recognized leader in lash, brow, and hair car...

2026-09-29 21:01 5579

Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses

Developed to fit around nursing workflows, ClinicalKey Nursing AI gives nurses fast, traceable answers to clinical questions at the point of care NEW YORK, Sept. 29, 2026 /PRNewswire/ -- Today Elsevier announced the global launch of ClinicalKey Nursing AI, the clinical AI tool built specifically ...

2026-09-29 20:00 1807

CAS announces collaboration with Novartis to advance AI-ready reaction informatics

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis  COLUMBUS, Ohio, Sept. 29, 2026 /PRNewswire/ -- CAS, a division of the American Chemical Society, today announced a collaboration with Novartis Bio...

2026-09-29 20:00 1743

Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board

CALGARY, AB, Sept. 29, 2026 /PRNewswire/ -- Providence Therapeutics Holdings, Inc. is pleased to announce formation of its initial Clinical Advisory Board. This advisory group will help steer Providence's therapeutic mRNA cancer vaccine programs, including the Company's personalized vaccine progr...

2026-09-29 19:00 1308

Vitaceuticals Founders Win National Manufacturing Award for Australian-Made Health Range

Pharmacists Sally Tadros and Cyndi Khawaja recognised at the 2026 Australian Women's Small Business Champion Awards. SYDNEY, Sept. 29, 2026 /PRNewswire/ -- Sydney pharmacists and sisters Sally Tadros and Cyndi Khawaja have won the Manufacturing category at the 2026 Australian Women's Small Busin...

2026-09-29 09:16 1237

Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor for the Treatment of Plaque Psoriasis

- 48.9% placebo-adjusted reduction in psoriasis area and severity index (PASI) score achieved in mild-to-moderate plaque psoriasis patients with once-daily 200 mg 28-day treatment. - Steady-state elimination half-life after 28-day treatment in patients was 6.5 days, supporting potential once-wee...

2026-09-29 08:00 2638

Regent Pacific (0575.HK)'s Deep Longevity Launches Accrua™ US Consumer Digital Health and Telehealth Platform

Available Across All 50 US States, Extending Deep Longevity's AI-Powered Ageing Science Directly to Consumers for a Second Growth Curve HONG KONG, Sept. 28, 2026 /PRNewswire/ -- Regent Pacific Group Limited (" Regent Pacific" or the "Company", together with its subsidiaries, the "Group"; stock co...

2026-09-28 23:29 4008

Heidi II puts agents to work on visit admin, giving clinicians more time with patients

Heidi II brings agentic capability into existing clinical workflows, moving from documenting the visit to doing the routine work around it with clinician supervision. MELBOURNE, Australia, Sept. 28, 2026 /PRNewswire/ -- Heidi , the AI Care Partner for leading clinic...

2026-09-28 21:00 2405

Link Cell Therapies Initiates Clinical Dosing with Logic-Gated CAR-T Therapy, Expands Executive Leadership, and Upsizes Series A Financing to $90 Million

– LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD Anderson Cancer Center – – Jie D'Elia, Ph.D., joins as Chief Executive Officer and Friedrich Graf Finckenstein, M.D., as Chief Medical Officer; c...

2026-09-28 18:59 2803

CityUHK researchers advance spatial omics to routine clinical use

HONG KONG, Sept. 28, 2026 /PRNewswire/ -- Recently, spatial omics has become a powerful tool, enabling researchers to see not only what molecules are present in a tissue, but also where they are located and how they are organised across cells, tissue structures and local microenvironments. This s...

2026-09-28 17:55 1880

Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters

* The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. * The move is part of Lundbeck's continued investment in the US, a key market, and will support the company's Focused In...

2026-09-25 15:52 3476

Greenfield Dental Market Insights: Rising Dental Costs Push Thousands of Western Patients to Vietnam

HANOI, Vietnam, Sept. 25, 2026 /PRNewswire/ -- Greenfield Dental has recorded a significant surge in international patient volume with over 300% growth since 2025, reflecting Vietnam's emergence as a premier dental tourism destination and Greenfield's growing reputation.

2026-09-25 14:17 2619

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth, pointing to a potential path toward earlier pregnancy-risk assessment. SINGAPORE, Sept. 25, 2026 /PRNewswire/...

2026-09-25 13:10 2860

Basecamp Research raises $140M to advance AI-designed therapeutics

/C O R R E C T I O N -- Basecamp Research/ In the news release, Basecamp Research raises $140M to advance AI-designed therapeutics, issued 23-Sep-2026 by Basecamp Research over PR Newswire, we are advised by the company that information has changed in the first bulleted subheadline and in the fo...

2026-09-25 01:44 2940

From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026

ZEISS Medical Technology advances its ZEISS Retina Workflow

2026-09-24 21:00 2925

Carestream Healthcare International Launches STARVIEW Digital Radiography System

SHANGHAI, Sept. 24, 2026 /PRNewswire/ -- Carestream Healthcare International announces the launch of theCARESTREAM STARVIEW Digital Radiography System, a focused, floor-mounted DR room designed for routine radiographic imaging. Healthcare facilities modernize radiography for different reasons, fr...

2026-09-24 14:07 1997

NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress

National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control. PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNew...

2026-09-24 08:03 2200

Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026

* 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion * Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 2027 * First-in-class PRS inhibitor being developed as a potential new therapeutic option...

2026-09-24 08:00 3114

CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements

The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care ROCHESTER, N.Y., Sept. 23, 2026 /PRNewswire/ -- CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six majo...

2026-09-23 22:15 3871

Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent

FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both ...

2026-09-23 20:00 1778
1 ... 567891011 ... 381